Basic Information
Basic information for LINC01821-210-45aa
Peptide Name LINC01821-210-45aa
Genome Position chr2:194344271-194344319,194350668-194350753[+]
Species Human
Peptide Sequence MQHKNFRDRRNLPLRADSKFFSFGTQTGSPCSSAHRWPIVGPCDR
Peptide Length 45
Unique Yes
Grand Average of Hydropathicity -0.9244
Relative Molecular Mass 5998.59
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000225539;LINC01821
Transcript ID/Name ENST00000659259;LINC01821-210
Transcript Length 1351
Coding Ability 0.4108
DNA Sequence Corresponding to Peptide ATGCAACATAAAAATTTCAGAGACAGAAGAAATCTTCCTTTGAGGGCAGACTCCAAGTTCTTCAGTTTTGGAACTCAGACTGGCTCTCCTTGCTCCTCAGCCCACAGATGGCCTATTGTGGGACCTTGTGATCGT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :